Literature DB >> 15207775

Increased expression of IL-6 and RANK mRNA in human trabecular bone from fragility fracture of the femoral neck.

Helen Tsangari1, David M Findlay, Julia S Kuliwaba, Gerald J Atkins, Nicola L Fazzalari.   

Abstract

Previous studies have implicated pro-inflammatory cytokines in the bone loss of estrogen deficiency. The aim of this study was to investigate the expression of key regulatory molecules of bone remodeling in the trabecular bone microenvironment in osteoporosis. Bone samples were taken from the intertrochanteric region of the proximal femur of patients undergoing total hip arthroplasty for a subcapital fragility fracture of the femoral neck (#NOF). For comparison, samples were taken from age-matched control individuals at routine autopsy. Expression of RANKL, RANK, osteoprotegerin (OPG), IL-6, IL-11, osteocalcin (OCN), and calcitonin receptor (CTR) messenger RNA (mRNA) species were analyzed and the data were nonparametrically distributed. The median expression of the proresorptive genes, RANK and IL-6, were significantly elevated in the fracture group compared to an age-matched control group (2.2 [1.9-2.9; 25th-75th percentiles] > 1.0 [0.4-2.1], P < 0.03; 3.9 [1.8-6.2] > 0.8 [0.7-1.5], P < 0.002, respectively). In contrast, there were no significant differences in expression of RANKL, OPG, CTR, or OCN mRNA between the #NOF and control groups. The median RANKL/OPG mRNA ratio was significantly greater in hip fracture bone than in bone from controls (4.8 [3.8-7.6] > 3.2 [2.1-4.0], P < 0.05). IL-6 mRNA levels associated strongly with RANKL mRNA levels in the #NOF group (r = 0.77, P < 0.001), but not in the control group. A strong positive association was found between IL-11 mRNA levels and RANKL mRNA levels in the #NOF group (r = 0.81, P < 0.001), consistent with the apparent coordinated regulation of IL-6 and IL-11 in bone samples from the #NOF group (r = 0.93, P < 0.0001). These data suggest a relative increase in the expression of the molecular promoters of osteoclast formation and activity in #NOF bone, which may lead to the imbalance between bone formation and resorption associated with fragility fracture.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15207775     DOI: 10.1016/j.bone.2004.02.006

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  18 in total

1.  Chronic inflammatory intestinal diseases and bone loss.

Authors:  M T Bardella; M L Bianchi; A Teti
Journal:  Gut       Date:  2005-10       Impact factor: 23.059

2.  Immune and inflammatory pathways are involved in inherent bone marrow ossification.

Authors:  Umut Atakan Gurkan; Ryan Golden; Vipuil Kishore; Catherine P Riley; Jiri Adamec; Ozan Akkus
Journal:  Clin Orthop Relat Res       Date:  2012-09       Impact factor: 4.176

Review 3.  The role of interleukin-6 in rheumatoid arthritis-associated osteoporosis.

Authors:  C J Edwards; E Williams
Journal:  Osteoporos Int       Date:  2010-03-13       Impact factor: 4.507

4.  The balance between soluble receptors regulating IL-6 trans-signaling is predictive for the RANKL/osteoprotegerin ratio in postmenopausal women with rheumatoid arthritis.

Authors:  Peter Oelzner; Sybille Franke; Gabriele Lehmann; Thorsten Eidner; Gert Hein; Gunter Wolf
Journal:  Rheumatol Int       Date:  2010-09-07       Impact factor: 2.631

5.  Triglyceride metabolism in bone tissue is associated with osteoblast and osteoclast differentiation: a gene expression study.

Authors:  Jana Dragojevič; Janja Zupan; Gregor Haring; Simon Herman; Radko Komadina; Janja Marc
Journal:  J Bone Miner Metab       Date:  2013-04-16       Impact factor: 2.626

6.  Elevated serum P1NP predicts development of bone metastasis and survival in early-stage breast cancer.

Authors:  Windy Dean-Colomb; Kenneth R Hess; Elliana Young; Terrie G Gornet; Beverly C Handy; Stacy L Moulder; Nuhad Ibrahim; Lajos Pusztai; Daniel Booser; Vicente Valero; Gabriel N Hortobagyi; Francisco J Esteva
Journal:  Breast Cancer Res Treat       Date:  2012-12-15       Impact factor: 4.872

Review 7.  The aging of the HIV epidemic.

Authors:  Kavita P Bhavan; Vinay N Kampalath; Edgar Turner Overton
Journal:  Curr HIV/AIDS Rep       Date:  2008-08       Impact factor: 5.071

Review 8.  Perspective on post-menopausal osteoporosis: establishing an interdisciplinary understanding of the sequence of events from the molecular level to whole bone fractures.

Authors:  L M McNamara
Journal:  J R Soc Interface       Date:  2009-10-21       Impact factor: 4.118

9.  Arthritogenic alphaviral infection perturbs osteoblast function and triggers pathologic bone loss.

Authors:  Weiqiang Chen; Suan-Sin Foo; Nestor E Rulli; Adam Taylor; Kuo-Ching Sheng; Lara J Herrero; Belinda L Herring; Brett A Lidbury; Rachel W Li; Nicole C Walsh; Natalie A Sims; Paul N Smith; Suresh Mahalingam
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-14       Impact factor: 11.205

10.  Potential mediators of the mortality reduction with zoledronic acid after hip fracture.

Authors:  Cathleen S Colón-Emeric; Peter Mesenbrink; Kenneth W Lyles; Carl F Pieper; Steven Boonen; Pierre Delmas; Erik F Eriksen; Jay Magaziner
Journal:  J Bone Miner Res       Date:  2010-01       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.